share_log

WHO expects to review Chinese vaccines on April 26 - official

WHO expects to review Chinese vaccines on April 26 - official

世卫组织预计将于4月26日审查中国疫苗-官方
Reuters ·  2021/04/09 21:47

GENEVA, April 9 (Reuters) - China&aposs COVID-19 vaccines, made by Sinopharm and Sinovac SVA.O , are in final stages of review for emergency use listing by the World Health Organization (WHO) which expects to decide on at least one at an April 26 meeting, its regulation director Rogerio Gaspar said on Friday.

路透日内瓦4月9日电-中国和阿波斯新冠肺炎疫苗,由中国医药集团和Sinovac SVA.O,正处于世界卫生组织(WHO)紧急用途清单审查的最后阶段,预计将至少决定在4月26日的一次会议上,其监管主管罗杰里奥·加斯帕(Rogerio Gaspar)周五表示。

A second meeting was planned for the week of May 3, which would allow for reviewing the second one as needed, he said.

他说,第二次会议计划在5月3日的那一周举行,届时将根据需要审查第二次会议。

WHO emergency use listing is a prequisite for being purchased by the COVAX vaccine-sharing facility and is also a signal to countries with weaker regulatory agencies about a vaccine&aposs safety and efficacy.

世卫组织紧急使用清单是被Covax疫苗共享机构购买的先决条件,也是向监管机构较弱的国家发出的关于疫苗&APOSS安全性和有效性的信号。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发